Russell Investments Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
83,061
+18,598
| +29% | +$288K | ﹤0.01% | 1938 |
|
|
2025
Q1 | $959K | Buy |
64,463
+19,139
| +42% | +$285K | ﹤0.01% | 2053 |
|
|
2024
Q4 | $600K | Buy |
45,324
+14,831
| +49% | +$196K | ﹤0.01% | 2215 |
|
|
2024
Q3 | $434K | Buy |
30,493
+13,036
| +75% | +$185K | ﹤0.01% | 2318 |
|
|
2024
Q2 | $226K | Buy |
17,457
+6,781
| +64% | +$87.7K | ﹤0.01% | 2448 |
|
|
2024
Q1 | $148K | Buy |
10,676
+4,213
| +65% | +$58.5K | ﹤0.01% | 2510 |
|
|
2023
Q4 | $92.2K | Sell |
6,463
-1,059
| -14% | -$15.1K | ﹤0.01% | 2568 |
|
|
2023
Q3 | $116K | Sell |
7,522
-526
| -7% | -$8.14K | ﹤0.01% | 2596 |
|
|
2023
Q2 | $126K | Buy |
8,048
+1,014
| +14% | +$15.9K | ﹤0.01% | 2561 |
|
|
2023
Q1 | $116K | Sell |
7,034
-99,028
| -93% | -$1.63M | ﹤0.01% | 2565 |
|
|
2022
Q4 | $1.65M | Hold |
106,062
| – | – | ﹤0.01% | 1707 |
|
|
2022
Q3 | $1.38M | Sell |
106,062
-314,313
| -75% | -$4.07M | ﹤0.01% | 1771 |
|
|
2022
Q2 | $5.9M | Buy |
420,375
+51,362
| +14% | +$721K | 0.01% | 1018 |
|
|
2022
Q1 | $5.28M | Sell |
369,013
-11,955
| -3% | -$171K | 0.01% | 1125 |
|
|
2021
Q4 | $5.19M | Buy |
380,968
+7,465
| +2% | +$102K | 0.01% | 1229 |
|
|
2021
Q3 | $6.12M | Buy |
373,503
+155,351
| +71% | +$2.54M | 0.01% | 1134 |
|
|
2021
Q2 | $3.67M | Buy |
+218,152
| New | +$3.67M | 0.01% | 1548 |
|
|
2020
Q3 | – | Sell |
-16,124
| Closed | -$289K | – | 3255 |
|
|
2020
Q2 | $289K | Buy |
+16,124
| New | +$289K | ﹤0.01% | 2589 |
|
|
2019
Q1 | – | Sell |
-26,395
| Closed | -$444K | – | 3008 |
|
|
2018
Q4 | $444K | Buy |
+26,395
| New | +$444K | ﹤0.01% | 2361 |
|